Saturday, 18 April 2020
U.S. Army Receives Remdesivir at No Cost
Back in March, the U.S. Army signed a deal with Gilead Sciences to receive Remdesivir at no cost to treat Covid-19. This is especially important given the recent study demonstrating Remdesivir as a potential effective treatment for Covid-19. The Military Times discusses the deal as well as work on a vaccine which started in January, here.